Peptide Injections AI
2026 FDA ReclassificationFrom $99/mo

Peptides for Women

From hormonal balance to body composition, peptide therapy offers targeted solutions for women's unique health needs.

Comparing 58 offers from 23 verified providers · Updated May 2026

ByChris Riley(CFA)&Alex Evans, PharmD, MBA(PharmD, MBA)|Updated

Women Peptide Prices (May 2026)

See all prices →
PT-1413 offers
Price range: $99 – $159/mo
1

PeterMD

PT-141 Injection · 1.75mg as needed

$99/mo

LOWEST PRICE
2

Defy Medical

PT-141 (Bremelanotide) · 1.75mg as needed

$125/mo

3

Ageless Rx

PT-141 · as needed

$159/mo

Semaglutide33 offers
Price range: $147 – $398/mo
1

TeleHealth Med

Compounded Semaglutide

$147/mo

LOWEST PRICE
2

Direct Meds

Semaglutide · weekly injection

$147/mo

3

Direct Meds

Semaglutide Oral Drops

$149/mo

4

Hims

Wegovy® Pill

$149/mo

GHK-Cu1 offer
Price range: $149 – $149/mo
1

Ageless Rx

GHK-Cu Peptide · topical

$149/mo

LOWEST PRICE
Tirzepatide20 offers
Price range: $149 – $1299/mo
1

Direct Meds

Tirzepatide Oral Drops

$149/mo

LOWEST PRICE
2

TeleHealth Med

Compounded Tirzepatide

$199/mo

3

Silhouette MD

Tirzepatide Injection

$299/mo

4

ShedRX

Compounded Tirzepatide Injection

$299/mo

Price range: $299 – $299/mo
1

Hims

Generic Liraglutide

$299/mo

LOWEST PRICE

Get price drop alerts

We'll notify you when women peptide prices drop at any provider.

Set Alert

Prices shown are estimates based on publicly available data and may not reflect current pricing. Actual costs may vary by location, insurance, dosage, and formulation. Always verify directly with the provider.

Women Peptide Therapy Overview

Women's peptide therapy addresses a range of conditions from perimenopause hormone fluctuations to post-pregnancy body composition changes. Key peptides include GLP-1s for weight management, PT-141 for libido, GHK-Cu for skin and hair, and Thymosin Alpha-1 for autoimmune conditions that disproportionately affect women.

  • Hormone optimization during perimenopause and menopause
  • Targeted weight management
  • Skin rejuvenation and collagen support
  • Libido and sexual health improvement
  • Immune modulation for autoimmune conditions

How Women Peptides Work

Peptide therapy for women addresses the unique hormonal landscape of the female body. GLP-1 agonists help with weight management that becomes more challenging during perimenopause as estrogen levels fluctuate, driving insulin resistance and central fat accumulation. PT-141 (Bremelanotide) is the only FDA-approved peptide for female hypoactive sexual desire disorder — it works through melanocortin receptors in the hypothalamus to enhance desire and arousal. GHK-Cu addresses the accelerated collagen loss that begins in women during their 30s and intensifies after menopause. Thymosin Alpha-1 modulates the immune system, which is particularly relevant since 80% of autoimmune disease patients are women — conditions like Hashimoto's, lupus, and rheumatoid arthritis can be supported with immune-modulating peptides.

Women Peptide Clinical Evidence & Data

FDA Approved for HSDD

Vyleesi (PT-141) Approval

PT-141 is the first and only FDA-approved treatment for hypoactive sexual desire in premenopausal women

80% of autoimmune patients

NIH Autoimmune Data

Women represent 80% of autoimmune cases — Thymosin Alpha-1 offers immune modulation rather than suppression

15–20% body weight loss

GLP-1 Female Cohort Data

Women in STEP/SURMOUNT trials showed comparable weight loss results to men with semaglutide and tirzepatide

Peptides Used for Women

Appetite regulation and metabolic health

FDA-approved for hypoactive sexual desire disorder in women

from $99/moLearn more →
GHK-CuCompoundedRFK 2026

Collagen production, skin and hair rejuvenation

from $149/moLearn more →
Thymosin Alpha-1CompoundedRFK 2026

Immune modulation for autoimmune conditions

Who Is Women Peptide Therapy For?

Women's peptide therapy is appropriate for adult women experiencing perimenopause or menopause symptoms (weight gain, sleep disruption, low libido, cognitive fog), post-pregnancy body composition challenges, autoimmune conditions requiring immune modulation, accelerated skin aging, or hair thinning. PT-141 is specifically indicated for premenopausal women with diagnosed HSDD. Contraindicated during pregnancy and breastfeeding. Women with hormone-sensitive cancers (breast, ovarian) should discuss GH-releasing peptides with their oncologist.

Typical Women Peptide Protocol

Women's peptide protocols require consideration of menstrual cycle, hormonal status, and reproductive goals. GLP-1 therapy follows the same titration schedule as for men (semaglutide 0.25mg → 2.4mg over 16 weeks) but providers should monitor bone density during rapid weight loss. PT-141 is dosed at 1.75mg SC as needed, max 1 dose per 24 hours. GHK-Cu for skin and hair can be combined topically and injectable (1–2mg/day). During perimenopause, providers often combine peptide therapy with bioidentical hormone replacement (BHRT). All peptide therapy should be paused during pregnancy and breastfeeding. Labs should include full hormone panel (estradiol, progesterone, testosterone, DHEA-S, thyroid), metabolic markers, and inflammatory markers.

Women Peptide News

News aggregated via Google News. Inclusion does not imply endorsement.

Women Guides & Resources

Women Peptide FAQs

Are peptides safe for women?

Many peptides are safe and effective for women when prescribed by a licensed provider. PT-141 (Bremelanotide) is specifically FDA-approved for women with hypoactive sexual desire disorder. GLP-1s have been extensively studied in female populations. Always discuss your full health history including pregnancy plans with your provider.

Can you take peptides while pregnant or breastfeeding?

Most peptide therapies are contraindicated during pregnancy and breastfeeding due to insufficient safety data. Consult your OB-GYN before starting or continuing any peptide protocol if you are pregnant, planning to become pregnant, or nursing.

What peptides help with menopause symptoms?

Sermorelin and CJC-1295/Ipamorelin can support growth hormone levels that decline during menopause, potentially improving sleep, body composition, and energy. Kisspeptin-10 is being studied for hormone regulation. These are complementary to, not replacements for, traditional hormone replacement therapy.

Medical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. Peptide therapies discussed here may not be FDA-approved for the listed indications. All prices shown are estimates based on publicly available data and may not reflect current pricing — providers and brands set their own prices and can change them at any time. Always verify pricing directly with the provider before purchasing. Consult a licensed healthcare provider before starting any peptide protocol.

Find a Provider for Women

Take our 2-minute quiz to get matched with a board-certified provider specializing in women peptide therapy.